pentobarbital will reduce the level or effect of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers might reduce partiaprevir and ritonavir stages, and as a consequence lowered efficacy of Viekira